Letter to our shareholders - November 2020
"Hunting in packs, a collaborative commercial approach hard-wired into Oncodesign’s genes" - Philippe GENNE, President and CEO of Oncodesign
Letters to Shareholders
Letter to our shareholders - April 2020
Here is our April 2020 issue which details the new organization of the Group into 3 Business Units. Interviews and articles on the menu.
Anatomy of the new face of Oncodesign: BU Service, BU Biotech & BU Artificial Intelligence.
Without forgetting the editorial by Ph. Genne entitled "how much is a human life worth".
"Behind any disaster, there is the promise of reconstruction and it is in this direction that we must look ..." - Philippe GENNE, President and CEO of Oncodesign
Letter to our shareholders - June 2019
"The health sector is in great need of innovations, & will continue to be for a long time yet" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.
Letter to our shareholders - November 2018
"I urge you all to stay aboard and keep your eyes firmly fixed on the future: we believe in it" says Philippe Genne, CEO & founder, Oncodesign Biotechnology.
